OCULIS ANNOUNCES POSITIVE FDA PRE-IND FEEDBACK SUPPORTING PRIVOSEGTOR DEVELOPMENT STRATEGY FOR TREATMENT OF ACUTE MULTIPLE SCLEROSIS RELAPSES

Reuters · 2d ago

Please log in to view news